Actively Recruiting
Real-World Data on the Effects of Cardiac Resynchronization Therapy in Adult Patients With Congenital Heart Disease
Led by Leiden University Medical Center · Updated on 2025-05-14
100
Participants Needed
1
Research Sites
782 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to evaluate the real-world effects of cardiac resynchronization therapy (CRT) in adult patients with congenital heart disease (ACHD). Specifically, it seeks to determine whether CRT improves clinical outcomes in this unique patient population and to identify factors associated with a favorable response to therapy.
CONDITIONS
Official Title
Real-World Data on the Effects of Cardiac Resynchronization Therapy in Adult Patients With Congenital Heart Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult congenital heart disease patients who have undergone cardiac resynchronization therapy implantation
You will not qualify if you...
- Younger than 18 years old at the time of cardiac resynchronization therapy implantation
- Patient objects to the use of retrospective data
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Leiden University Medical Center (LUMC)
Leiden, South Holland, Netherlands, 2333ZA
Actively Recruiting
Research Team
A
Anastasia D. Egorova, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here